戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  means they influence the pathophysiology of pneumococcal meningitis.
2 e associated with morbidity and mortality of pneumococcal meningitis.
3 long-term hearing function in a rat model of pneumococcal meningitis.
4 IgR and PECAM-1 has the potential to prevent pneumococcal meningitis.
5 in CSF specimens from patients and mice with pneumococcal meningitis.
6 ammation and potential therapeutic target in pneumococcal meningitis.
7 ions for use of adjunctive dexamethasone for pneumococcal meningitis.
8  be associated with outcome in patients with pneumococcal meningitis.
9 t of CNS inflammation in an in vivo model of pneumococcal meningitis.
10                  We identified 1379 cases of pneumococcal meningitis.
11 in play crucial roles in the pathogenesis of pneumococcal meningitis.
12 is plays in neuronal death in the context of pneumococcal meningitis.
13 rognosis for patients, especially those with pneumococcal meningitis.
14 e to the neuropathology commonly observed in pneumococcal meningitis.
15 en and adults with haemophilus meningitis or pneumococcal meningitis.
16 uggesting new neuroprotective strategies for pneumococcal meningitis.
17 ironment needed to establish nonhematogenous pneumococcal meningitis.
18 ebrospinal fluid compartment in experimental pneumococcal meningitis.
19  fatality was 8% (25/329) and was higher for pneumococcal meningitis (5/26 [19%]) than GBS meningitis
20  in the cerebrospinal fluid of patients with pneumococcal meningitis (6.8 to 3,900 ng of muramic acid
21 lysis was restricted to patients with proven pneumococcal meningitis (68 of 129 patients receiving co
22 genetic marker of morbidity and mortality of pneumococcal meningitis and also suggests a potential ro
23                               In conclusion, pneumococcal meningitis and herpes simplex encephalitis
24 tive, nationwide cohort of 405 patients with pneumococcal meningitis and in 329 controls matched for
25 multaneous in vivo biophotonic monitoring of pneumococcal meningitis and the accompanying neuronal in
26 5 years with H influenzae, meningococcal and pneumococcal meningitis, and septicaemia.
27               The mortality and morbidity of pneumococcal meningitis are still devastating, and resul
28  association study in 469 community-acquired pneumococcal meningitis cases and 2072 population-based
29         As apoptosis drives neuronal loss in pneumococcal meningitis, caspase inhibitors might provid
30                               Mortality from pneumococcal meningitis decreased between 2005 (0.049 pe
31  reducing the incidence of hearing loss from pneumococcal meningitis, especially if therapy is instit
32                        We examined trends in pneumococcal meningitis from 1998 through 2005 using act
33                                              Pneumococcal meningitis had the highest case fatality ra
34            Their role in the pathogenesis of pneumococcal meningitis has not been addressed.
35                                     Rates of pneumococcal meningitis have decreased among children an
36 llin-susceptible and cephalosporin-resistant pneumococcal meningitis in rabbits, staphylococcal and e
37  investigated the progression and outcome of pneumococcal meningitis in Rag1(-/-) mice lacking functi
38   To better understand the high incidence of pneumococcal meningitis in the African meningitis belt,
39 ective antibody seroprevalence in preventing pneumococcal meningitis in the meningitis belt requires
40    Despite a substantially higher historical pneumococcal meningitis incidence in Burkina Faso, the g
41  role played by pneumolysin and autolysin in pneumococcal meningitis is poorly understood.
42                                              Pneumococcal meningitis is the most frequent and critica
43 te vaccine (PCV7) in 2000, but its effect on pneumococcal meningitis is unclear.
44                            Poor prognosis in Pneumococcal meningitis may be associated with high pneu
45 ubjects (controls, n = 10) and patients with pneumococcal meningitis (n = 20) was analyzed.
46                                Patients with pneumococcal meningitis often die or have severe neurolo
47 y of being employed as a former patient with pneumococcal meningitis or herpes simplex encephalitis v
48 nt pneumococcal conjugate vaccine (PCV13) on pneumococcal meningitis (PM) in US children is unknown.
49      Hearing loss is an important sequela of pneumococcal meningitis (PM), occurring in up to 30% of
50 occurring in up to 30% of patients surviving pneumococcal meningitis (PM).
51                              In experimental pneumococcal meningitis, pneumolysin colocalized with ap
52 te recent advances in antimicrobial therapy, pneumococcal meningitis remains a life-threatening disea
53                                              Pneumococcal meningitis remains a significant cause of m
54           Subgroup analysis on patients with pneumococcal meningitis showed similar results.
55 tween multiple variants in a gene region and pneumococcal meningitis susceptibility yielded one signi
56 der to find genetic variants associated with pneumococcal meningitis susceptibility.
57 rabbit model of hearing loss in experimental pneumococcal meningitis to evaluate the therapeutic effe
58 pectively) in the progression and outcome of pneumococcal meningitis, using Kaplan-Meier survival cur
59                                              Pneumococcal meningitis was diagnosed in 77% of patients
60  of brain biopsies from patients who died of pneumococcal meningitis, we observe that pneumococci col
61                  Changes in the incidence of pneumococcal meningitis were assessed against baseline v
62         Two apparently linked fatal cases of pneumococcal meningitis were investigated.
63 st signals associated with susceptibility to pneumococcal meningitis were rs139064549 on chromosome 1
64 nctive steroid treatment is underutilized in pneumococcal meningitis, where it has shown to decrease
65 f all patients and in 39.3% of patients with pneumococcal meningitis, with an associated decrease in

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。